How the contract works
A contract on this question settles at $1 if Unitree completes an IPO by 31 December 2026 and its closing market capitalization on the first trading day exceeds ¥100 billion, and at $0 otherwise. Market capitalization is calculated as total outstanding shares, across all share classes with conversion ratios applied, multiplied by the official closing price on that first day. The price of the contract at any moment simply reflects what buyers and sellers currently think the chance of that outcome is; a contract priced at 0.30, for example, would imply the market sees roughly a three-in-ten chance, though that is not this market's current level. The question settles based on official company filings and the primary listing exchange's closing price data, with resolution by 1 January 2027, and a position can typically be sold before that date at whatever price the market has moved to.
Yes99%
No1%
Probability
How the price has moved
Only one venue, Predict.fun, has recorded trading on this question, with all $3,453,799 in volume there and a consensus reading of 99%. With a single venue and no reported divergence, there is no cross-venue spread to interpret, and the figures available do not show a distinct move over the past day or week. A probability sitting this close to certainty with concentrated volume in one place reads as a market that considers the valuation question close to settled, with essentially all of the remaining uncertainty attached to whether the IPO happens on schedule at all.
Analysis
Context
Unitree Robotics is a Hangzhou-based robotics maker founded by Wang Xingxing in 2016, known first for its quadruped robots and now for humanoid robots such as the H1 and G1 series. It has become one of the most closely watched companies in China's push into humanoid robotics, a field also being pursued by Tesla, Figure AI and Boston Dynamics. Unitree entered China's IPO counseling process during 2025, a required regulatory step before listing on a mainland exchange such as Shanghai's STAR Market, which is the venue widely expected to host any offering. The company's private valuation has climbed sharply across successive funding rounds as investor interest in humanoid robotics intensified through 2025.
The consensus across venues sits at 99%, with all $3,453,799 of recorded volume concentrated on a single venue, Predict.fun. A probability this close to certainty, with volume clustered in one place rather than split across competing venues, tells a fairly simple story: the trading population sees very little genuine uncertainty left in the valuation question itself. That is consistent with what is publicly known about Unitree's finances. The company has already cleared valuation levels well above ¥100 billion in private funding rounds during 2025, driven by a wave of investor enthusiasm for humanoid robotics that also lifted valuations at comparable firms internationally. For the IPO to close below ¥100 billion, either the offering would need to be priced at a steep discount to Unitree's last private valuation, or the broader robotics investment theme would need to have cooled sharply by the listing date. Neither is impossible, but neither is what the current pricing reflects. The residual 1% priced against a YES outcome is better read as the market's estimate of execution risk than valuation risk: the chance that the IPO is delayed past the 31 December 2026 cutoff, is priced down materially in a weak market window, or that regulatory review in China's IPO counseling process runs long. China's IPO approval process for large, high-profile companies has in the past taken longer than initial timelines suggested, and a company of Unitree's visibility is likely to draw close regulatory scrutiny of its financials and share structure before any listing is approved. That single-venue, high-volume, high-confidence pricing pattern is the clearest signal on this page: traders are not debating whether Unitree is worth ¥100 billion, they are pricing the small chance that the listing itself does not happen cleanly on schedule.
What moves the probability
Private valuation trajectory
Unitree's valuation in private funding rounds through 2025 has reportedly climbed well past the ¥100 billion mark, which anchors expectations for where an IPO would price. This pushes the probability up, since the IPO valuation would need to fall sharply from recent private marks to miss the threshold.
Chinese IPO approval timeline
Unitree's listing depends on completing China's IPO counseling and regulatory review process, most likely for the Shanghai STAR Market. Delays in that process are the main way this question could resolve NO, since a late or stalled review could push any listing past the 31 December 2026 cutoff.
Global humanoid robotics sentiment
Investor enthusiasm for humanoid robots, fueled by parallel developments at Tesla, Figure AI and others, has lifted valuations across the sector through 2025. A cooling of that sentiment before listing day would weigh on Unitree's IPO pricing, though it would need to be a large reversal to bring the valuation under ¥100 billion given the current gap.
First-day pricing volatility
Even with a high offering valuation, first-day trading in newly listed shares can move sharply in either direction. Since the resolution uses the closing price on the first trading day specifically, unusual volatility on that single day carries outsized weight relative to the underlying business valuation.
The case for
- Unitree has already been valued above the ¥100 billion threshold in disclosed private funding rounds during 2025.
- Unitree is widely regarded as a leading Chinese humanoid robot maker, a position that supports strong demand from IPO investors.
- Global capital markets have shown strong appetite for humanoid robotics companies through 2025, supporting comparable valuations at listing.
- Completing the IPO before 31 December 2026 would lock in resolution under current market conditions rather than a later, less certain window.
The case against
- If Unitree's IPO counseling and regulatory review in China run past 31 December 2026, the question resolves NO regardless of what valuation it might eventually achieve.
- A broader downturn in technology or robotics equity valuations before the listing date could compress the IPO price below recent private funding levels.
- Underwriters could price a more conservative offering than recent private rounds suggest, particularly if regulators push for a lower valuation multiple.
- The closing price on a single first trading day is the specific figure that resolves this question, and first-day volatility could in principle pull the close below the threshold even if the offering itself was priced above it.
What to watch
The key dates ahead are any formal announcements from China's securities regulator or the Shanghai Stock Exchange regarding Unitree's IPO counseling status, any prospectus filing that would confirm a listing timetable, and the actual listing date itself, which must fall by 31 December 2026 for this question to have any chance of resolving YES. Any disclosed valuation figures in a prospectus or updated funding round before listing would also sharpen the picture, as would signs of delay in the regulatory review process.
Trade this contract
Open on Predict.fun
- yield on collateral
